These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8531667)

  • 21. Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice.
    Smooker PM; Kennedy NJ; Steeper KR; Christopoulos H; Spithill TW
    Exp Parasitol; 2001 Mar; 97(3):154-60. PubMed ID: 11312577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and partial characterization of an antigen shared between Schistosoma mansoni, Fasciola hepatica, and Biomphalaria glabrata.
    Rasmussen KR; Hillyer GV; Kemp WM
    J Parasitol; 1985 Dec; 71(6):792-8. PubMed ID: 2419536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.
    Torres D; Espino AM
    Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
    Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
    J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
    Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
    Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein.
    Rodríguez-Pérez J; Rodríguez-Medina JR; García-Blanco MA; Hillyer GV
    Exp Parasitol; 1992 Jun; 74(4):400-7. PubMed ID: 1592092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired immunity in schistosomiasis with purified Fasciola hepatica cross-reactive antigens.
    Hillyer GV; Soler de Galanes M; García Rosa MI; Montealegre F
    Vet Parasitol; 1988 Sep; 29(2-3):265-80. PubMed ID: 3144081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein.
    Espino AM; Hillyer GV
    J Parasitol; 2001 Apr; 87(2):426-8. PubMed ID: 11318577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
    Mendes RE; Zafra R; Pérez-Ecija RA; Buffoni L; Martínez-Moreno A; Tendler M; Pérez J
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):698-705. PubMed ID: 20835620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking Fasciola hepatica's energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase.
    Jaros S; Jaros D; Wesolowska A; Zygner W; Wedrychowicz H
    Vet Parasitol; 2010 Sep; 172(3-4):229-37. PubMed ID: 20538413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reevaluation of the potential of Fasciola hepatica antigens for immunization against Schistosoma mansoni infection.
    Ford MJ; Taylor MG; Bickle QD
    Parasitology; 1987 Apr; 94 ( Pt 2)():327-36. PubMed ID: 3108833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle.
    Estuningsih SE; Smooker PM; Wiedosari E; Widjajanti S; Vaiano S; Partoutomo S; Spithill TW
    Int J Parasitol; 1997 Nov; 27(11):1419-28. PubMed ID: 9421734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
    Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
    Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm.
    Brito CF; Oliveira GC; Oliveira SC; Street M; Riengrojpitak S; Wilson RA; Simpson AJ; Correa-Oliveira R
    Braz J Med Biol Res; 2002 Mar; 35(3):377-81. PubMed ID: 11887217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
    Martins VP; Morais SB; Pinheiro CS; Assis NR; Figueiredo BC; Ricci ND; Alves-Silva J; Caliari MV; Oliveira SC
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2750. PubMed ID: 24651069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of purified antigens in haemagglutination test (IHA) for determination of cross reactivities in diagnosis of fascioliasis and schistosomiasis.
    Azab M el-S ; el Zayat EA
    J Egypt Soc Parasitol; 1996 Dec; 26(3):677-85. PubMed ID: 8918041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.